Tarsus Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
43.3M
on 2026-06-30, from 37.7M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
6 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
$449.7M
Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-08-05 | Private placement incl. 0.13M pre-funded | 267,250 | $56.00 | not stated | 8-K ↗ |